EHA Fellowship Winners

The EHA Fellowship Winners of 2010 have received their award during the 15th Congress: Oxana Bereschenko, Florian Kuchenbaue...

 

Fellowship Program

The aim of the EHA Fellowship Program is to promote European hematological research and to support young basic and clinical...

 

EHA-ASH Research Exchange Award

Effective April 1, 2010 the EHA-ASH Exchange Award has been discontinued. EHA and ASH will not be accepting applications aft...

 

E H A / Fellowships

Fellowships

Application for the research fellowships is closed. The winners of 2010 will be announced during the 15th Congress of EHA in Barcelona.

The aim of the program is to promote European hematological research and in particular to support junior basic and clinical researchers in the development of their careers.

EHA FELLOWSHIP PROGRAM

One of EHA's goals is to promote the career development of junior scientists involved in basic, clinical and experimental research in hematology. EHA funds research fellowships, including the long-established José Carreras Foundation - EHA Young Investigator Fellowship, for researchers in the field of malignant and non-malignant hematology. Each grant is for a two-year period.

Read more »

   

Winners »

EHA-ASH Research Exchange Award

The EHA-ASH Research Exchange Award was offered for the first time in 2006. This new award has been developed as a partnership between the European Hematology Association (EHA) and the American Society of Hematology (ASH) to provide hematologists in training or early in their careers the opportunity to conduct research in another country. Read more »

EHA-ASH Award winners 2009

Dr. Freda Passam, MD, PhD
Home institution: Medical School of Crete, Greece
Host institution: Research Center of Thrombosis and Hemostasis at the Beth Israel Deaconess Medical Center in Boston, United States
Title: "Role of the thiol isomerase ERp5 in thrombus formation"

Dr. Carmen Schweighofer, MD
Home institution: University of Cologne, Germany
Host Institute: The University of Texas M. D. Anderson Cancer Center, United States
Title: "Genomic aberrations predict outcome in patient with chronic lymphocytic leukemia (CLL) treated with frontline FCR chemoimmunotherapy"

Last updated on Monday 10 May 2010.